AK

Asha Kejriwal

Active Director Director DIN 01091737
DIN 01091737 First appointment Nov 1995 Primary industry Financial Services
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 1995
Shareholding value •••• Premium profile

About Asha Kejriwal

Data last updated:

Asha Kejriwal is a Director at Mataco Pharmaceutical Pvt Ltd (since 1995). The company operates in Financial Services. Mataco Pharmaceutical Pvt Ltd reported revenue of ₹67,225 (FY 2022).

DIN 01091737
Primary Designation Director
Industry Financial Services
First Appointment 20 Nov 1995
Oldest Company Age 38 yrs
Largest company Mataco Pharmaceutical Pvt Ltd · ₹67,225 (FY 2022)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Mataco Pharmaceutical Pvt Ltd U24299WB1988PTC044980
Director20 Nov 19951988₹67,225 (FY 2022)Active

Board colleagues of Asha Kejriwal

NameDINCompanyDesignation
Girdhari Lal Khemani00660797Mataco Pharmaceutical Pvt LtdDirector

Directorship timeline

Open interactive timeline →
Mataco Pharmaceutical Pvt Ltd
Premium access

Shareholding and investment profile for Asha Kejriwal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Asha Kejriwal

Asha Kejriwal currently holds 1 directorship: Mataco Pharmaceutical Pvt Ltd (Director, since 20 Nov 1995, revenue ₹67,225 (FY 2022)).

Asha Kejriwal was first appointed on 20 Nov 1995 as Director at Mataco Pharmaceutical Pvt Ltd.

The current boards of Asha Kejriwal's companies include Girdhari Lal Khemani (Mataco Pharmaceutical Pvt Ltd).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available